Platelet-Rich Plasma vs. Placebo for Achilles Tendon Rupture: 2 Year Outcomes
Platelet-rich plasma injection for acute Achilles tendon rupture : two-year follow-up of the PATH-2 randomized, placebo-controlled, superiority trialBone Joint J. 2022 Nov;104-B(11):1256-1265.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
182/230 patients from the PATH-2 trial responded to this 2-year follow-up study of the PATH-2 trial comparing platelet-rich plasma (PRP; n=88/114) and placebo (92/116). The outcomes of interest included the Achilles Tendon Rupture Score (ATRS), the Patient-Specific Functional Scale (PSFS), and the Short-Form 12 (SF-12) mental and physical component quality of life scores. The results of this study...